StockNews.com initiated coverage on shares of OncoSec Medical (NASDAQ:ONCS – Free Report) in a research note issued to investors on Monday. The firm issued a sell rating on the biotechnology company’s stock. OncoSec Medical Stock Performance The firm has a 50 day simple moving average of $0.60 and a 200 day simple moving average of […]